SlideShare ist ein Scribd-Unternehmen logo
1 von 46
Does Catalonia
Need a Chief Science Officer / Advisor ?
Mehrdad Hariri
CEO & Founder Canadian Science Policy Centre
BioCat Forum
Nov. 25 2016
Hello, Bonjour from CANADA
Global Challenges
“Does Catalonia need a Chief Scientist?”, MEHRDAD HARIRI
“Does Catalonia need a Chief Scientist?”, MEHRDAD HARIRI
“Does Catalonia need a Chief Scientist?”, MEHRDAD HARIRI
“Does Catalonia need a Chief Scientist?”, MEHRDAD HARIRI
“Does Catalonia need a Chief Scientist?”, MEHRDAD HARIRI
“Does Catalonia need a Chief Scientist?”, MEHRDAD HARIRI
“Does Catalonia need a Chief Scientist?”, MEHRDAD HARIRI
New institutions of science policy
“Does Catalonia need a Chief Scientist?”, MEHRDAD HARIRI
Bosch-Capblanch X, Lavis JN, Lewin S, Atun R, Røttingen J-A, Dröschel D, et al. (2012) Guidance for Evidence-Informed Policies
about Health Systems: Rationale for and Challenges of Guidance Development. PLoS Med 9(3): e1001185.
doi:10.1371/journal.pmed.1001185
Cycle of Interaction:
Science Society Policy Maker
Adopted from: http://weadapt.org/
“Does Catalonia need a Chief Scientist?”, MEHRDAD HARIRI
“Does Catalonia need a Chief Scientist?”, MEHRDAD HARIRI
• the complexity, multidisciplinary,
and ever-changing nature of science
and technology of the 21st century
requires efficient, energetic and agile
institutions to ensure the
interconnection among various
elements of innovation system,
including the society at large.
“Does Catalonia need a Chief Scientist?”, MEHRDAD HARIRI
“Does Catalonia need a Chief Scientist?”, MEHRDAD HARIRI
“Does Catalonia need a Chief Scientist?”, MEHRDAD HARIRI
• Sputnik slide
“Does Catalonia need a Chief Scientist?”, MEHRDAD HARIRI
Why science adviser / officer
Officer vs Advisor
Chief Science Officer (CSO) Chief Science Advisor (CSA)
Responsible for capacity development of
the overall science enterprise or
government funded science
Responsible for providing independent
scientific advice to the Prime Minister
and the cabinet
Officer vs Advisor
Chief Science Officer (CSO) Chief Science Advisor (CSA)
Responsible for capacity development of
the overall science enterprise or
government funded science
Responsible for providing independent
scientific advice to the Prime Minister
and the cabinet
Jurisdiction: Policy for Science Jurisdiction: Science for Policy
Officer vs Advisor
Chief Science Officer (CSO) Chief Science Advisor (CSA)
Responsible for capacity development of
the overall science enterprise or
government funded science
Responsible for providing independent
scientific advice to the Prime Minister
and the cabinet
Jurisdiction: Policy for Science Jurisdiction: Science for Policy
Ensures the well-being of the science
enterprise, its management,
coordination, and collaboration,
domestically and internationally
Provides the best scientific advice on
emerging matters for high-level decision-
making.
Officer vs Advisor
Chief Science Officer (CSO) Chief Science Advisor (CSA)
Responsible for capacity development of
the overall science enterprise or
government funded science
Responsible for providing independent
scientific advice to the Prime Minister
and the cabinet
Jurisdiction: Policy for Science Jurisdiction: Science for Policy
CEO of Science Enterprise/ or
Government Science (depending on the
extension of mandate)
No Formal Executive Responsibility
Ensures the well-being of the science
enterprise, its management,
coordination, and collaboration,
domestically and internationally
Provides the best scientific advice on
emerging matters for high-level decision-
making.
Officer vs Advisor
Chief Science Officer (CSO) Chief Science Advisor (CSA)
Responsible for capacity development of
the overall science enterprise or
government funded science
Responsible for providing independent
scientific advice to the Prime Minister
and the cabinet
Jurisdiction: Policy for Science Jurisdiction: Science for Policy
CEO of Science Enterprise/ or
Government Science (depending on the
extension of mandate)
No Formal Executive Responsibility
Functions as part of the Ministry of
Science and or Innovation
Independent, Arm’s Length office,
functioning under the PMO
Ensures the well-being of the science
enterprise, its management,
coordination, and collaboration,
domestically and internationally
Provides the best scientific advice on
emerging matters for high-level decision-
making.
Science Advisory: USA
The Office of Science and Technology Policy
(OSTP) is a department of the United States
government, part of the Executive Office of the
President (EOP), established by the United
States Congress in 1976,
broad mandate to advise the President on the
effects of science and technology on domestic
and international affairs.
Science Advisory: USA
Mission:
1.To provide the President and his senior staff with accurate, relevant,
and timely scientific and technical advice on all matters of consequence;
2.To ensure that the policies of the Executive Branch are informed by
sound science
3.Too ensure that the scientific and technical work of the Executive
Branch is properly coordinated so as to provide the greatest benefit to
society.
“Does Catalonia need a Chief Scientist?”, MEHRDAD HARIRI
Science Advisory: UK
Every government department has a chief scientific Advisor
(CSA).
Departmental CSAs work together under the leadership of the
Government’s Chief Scientific Advisor to support each other
and to address and advise on cross-cutting issues.
They do this primarily through the Chief Scientific Advisors
network. The network advises the Government Chief Scientific
Advisor on all aspects of policy on science and technology.
Science Advisory: UK
In particular, they:
1. Provide advice to ministers, through the Cabinet committee system
2. Discuss and facilitate implementation of policy on science, technology,
engineering and mathematics (STEM)
3. Identify and share good practices in STEM-related areas, including the
use of scientific advice in policy-making
4. Facilitate communication on particular high profile STEM-related issues
and those posing new challenges for government
Science Advisory: New Zealand
Science Advisory: New Zealand
The primary task of the Chief Scientific Advisor is to provide the Prime Minister
strategic and operational advice on science and science policy issues. Other
tasks include:
1.Advise on matters of science policy in areas where the Prime Minister specifically
requests. 
2.Advise Prime Minister on specific matters related to science
3.Promote the public understanding of, and engagement with, science, particularly with
young people.
4.Build international relationships. Science can be an important diplomatic tool, generating
trust and confidence between nations and opening strategic opportunities for cooperation.
5.Serve as a conduit of alerts that might arise where scientific progress shows either
opportunity or threat for New Zealand. 
Science Advisory: Australia
Science Advisory: Australia
The world, and Australia with it, is faced with increasingly complex challenges
and opportunities, most of which require significant input from science in order to
address them fully and appropriately.
It is essential then, that the Australian available, to be used to help inform the
best course of action for Australian Government has access to the highest
calibre independent, and authoritative scientific advice.
The Chief Scientist has the opportunity to help bring together extensive national
and international scientific networks to assist in providing the most up to date and
scientifically robust advice.
Through international networks the Chief Scientist is also able to help discuss
and affect this at a global level. This is a key and unique aspect of the role.
Science and Technology and innovation Council
(STIC)
Scotland
Scotland
Provides expert scientific advice to the Scottish Government
about science-related issues, evidence and new developments
that may have an impact on the Scottish Government's work
Champions the use of science to inform policy development
across the Scottish Government
Supports Scotland's world-leading science base and its potential
to benefit Scotland's economy, people and environment
Quebec
•To advise the Minister of Economy, Science and Innovation
on matters pertaining to the development of research and
science;
•To chair the Boards of Directors of each of the three research
funds;
•To coordinate issues of common concern to the three funds
and cross-sectoral research activities;
•To ensure the consolidation and integration of the three
research funds’ administrative activities;
•To promote careers in research and scientific culture.
Does Catalonia
Need a Chief Science Officer / Advisor ?
Determinant of such office
• Objectives
• Stakeholders consultation
Innovation Systems
Adopted from:
Review of federal support for R&D
QUESTIONS
QUESTIONS

Weitere ähnliche Inhalte

Andere mochten auch

Presentation done by Marta Marse Virdi
Presentation done by Marta Marse VirdiPresentation done by Marta Marse Virdi
Presentation done by Marta Marse VirdiDr. Amit Kapoor
 
Common Myths In Fitness - 6
Common Myths In Fitness - 6Common Myths In Fitness - 6
Common Myths In Fitness - 6Miss Bee
 
95501891 jueves-31-de-mayo-de-2012
95501891 jueves-31-de-mayo-de-201295501891 jueves-31-de-mayo-de-2012
95501891 jueves-31-de-mayo-de-2012Rina Rosa
 
90tools90minutes westmere 19 05-2010
90tools90minutes westmere 19 05-201090tools90minutes westmere 19 05-2010
90tools90minutes westmere 19 05-2010David Kinane
 
QCL520 Social Studies Interactive Lecture
QCL520 Social Studies Interactive LectureQCL520 Social Studies Interactive Lecture
QCL520 Social Studies Interactive LectureGoh Bang Rui
 
Introduction to en world Singapore
Introduction to en world SingaporeIntroduction to en world Singapore
Introduction to en world Singaporeen world
 
Singapore An economic miracle
Singapore An economic miracleSingapore An economic miracle
Singapore An economic miracleOto Sikharulidze
 
Macro-Economics Case Analysis: Singapore - a unique economy
Macro-Economics Case Analysis: Singapore - a unique economyMacro-Economics Case Analysis: Singapore - a unique economy
Macro-Economics Case Analysis: Singapore - a unique economyMadhuranath R
 
Financial Markets In Singapore
Financial Markets In SingaporeFinancial Markets In Singapore
Financial Markets In SingaporeAjay Panandikar
 
Singapur's economic model Office power point
Singapur's economic model Office power pointSingapur's economic model Office power point
Singapur's economic model Office power pointAidana Andekina
 
Landscape Catalogues: To Improve the Knowledge And To Act. Experiences In Cat...
Landscape Catalogues: To Improve the Knowledge And To Act. Experiences In Cat...Landscape Catalogues: To Improve the Knowledge And To Act. Experiences In Cat...
Landscape Catalogues: To Improve the Knowledge And To Act. Experiences In Cat...Pere Sala i Martí
 
Chapter 5 - How external events affect Singapore?
Chapter 5 - How external events affect Singapore?Chapter 5 - How external events affect Singapore?
Chapter 5 - How external events affect Singapore?Irving Quah
 
Intel Roadmap 2010
Intel Roadmap 2010Intel Roadmap 2010
Intel Roadmap 2010Umair Mohsin
 

Andere mochten auch (20)

Presentation done by Marta Marse Virdi
Presentation done by Marta Marse VirdiPresentation done by Marta Marse Virdi
Presentation done by Marta Marse Virdi
 
Common Myths In Fitness - 6
Common Myths In Fitness - 6Common Myths In Fitness - 6
Common Myths In Fitness - 6
 
95501891 jueves-31-de-mayo-de-2012
95501891 jueves-31-de-mayo-de-201295501891 jueves-31-de-mayo-de-2012
95501891 jueves-31-de-mayo-de-2012
 
90tools90minutes westmere 19 05-2010
90tools90minutes westmere 19 05-201090tools90minutes westmere 19 05-2010
90tools90minutes westmere 19 05-2010
 
QCL520 Social Studies Interactive Lecture
QCL520 Social Studies Interactive LectureQCL520 Social Studies Interactive Lecture
QCL520 Social Studies Interactive Lecture
 
Branding Singapore
Branding SingaporeBranding Singapore
Branding Singapore
 
Singapore vs India Economically
Singapore vs India EconomicallySingapore vs India Economically
Singapore vs India Economically
 
Una estrategia industrial per a Catalunya
Una estrategia industrial per a CatalunyaUna estrategia industrial per a Catalunya
Una estrategia industrial per a Catalunya
 
Introduction to en world Singapore
Introduction to en world SingaporeIntroduction to en world Singapore
Introduction to en world Singapore
 
Catalonia in-world-competitiveness-report-2014
Catalonia in-world-competitiveness-report-2014Catalonia in-world-competitiveness-report-2014
Catalonia in-world-competitiveness-report-2014
 
Singapore An economic miracle
Singapore An economic miracleSingapore An economic miracle
Singapore An economic miracle
 
Macro-Economics Case Analysis: Singapore - a unique economy
Macro-Economics Case Analysis: Singapore - a unique economyMacro-Economics Case Analysis: Singapore - a unique economy
Macro-Economics Case Analysis: Singapore - a unique economy
 
Tw22
Tw22Tw22
Tw22
 
Financial Markets In Singapore
Financial Markets In SingaporeFinancial Markets In Singapore
Financial Markets In Singapore
 
Singapur's economic model Office power point
Singapur's economic model Office power pointSingapur's economic model Office power point
Singapur's economic model Office power point
 
Landscape Catalogues: To Improve the Knowledge And To Act. Experiences In Cat...
Landscape Catalogues: To Improve the Knowledge And To Act. Experiences In Cat...Landscape Catalogues: To Improve the Knowledge And To Act. Experiences In Cat...
Landscape Catalogues: To Improve the Knowledge And To Act. Experiences In Cat...
 
Chapter 5 - How external events affect Singapore?
Chapter 5 - How external events affect Singapore?Chapter 5 - How external events affect Singapore?
Chapter 5 - How external events affect Singapore?
 
Intel Roadmap 2010
Intel Roadmap 2010Intel Roadmap 2010
Intel Roadmap 2010
 
Remaking singapore
Remaking singaporeRemaking singapore
Remaking singapore
 
Nanotechnology and CHIP Fabrication
Nanotechnology and CHIP FabricationNanotechnology and CHIP Fabrication
Nanotechnology and CHIP Fabrication
 

Ähnlich wie “Does Catalonia need a Chief Scientist?”, MEHRDAD HARIRI

science_of_science_policy_roadmap_2008
science_of_science_policy_roadmap_2008science_of_science_policy_roadmap_2008
science_of_science_policy_roadmap_2008Avery Sen
 
Policy Workshop Introduction by Dr Michael Elves
Policy Workshop Introduction by Dr Michael ElvesPolicy Workshop Introduction by Dr Michael Elves
Policy Workshop Introduction by Dr Michael ElvesJeremy LeLean
 
Science advice to government - Auckland conference
Science advice to government - Auckland conferenceScience advice to government - Auckland conference
Science advice to government - Auckland conferencebis_foresight
 
Stevenage Bioscience Catalyst: annual lecture 2014
Stevenage Bioscience Catalyst: annual lecture 2014Stevenage Bioscience Catalyst: annual lecture 2014
Stevenage Bioscience Catalyst: annual lecture 2014bis_foresight
 
Science, Technology & Knowledge Economy
Science, Technology & Knowledge Economy Science, Technology & Knowledge Economy
Science, Technology & Knowledge Economy Sandipan Dhar
 
2010 Mid West Science Summit | Inspiring Australia
2010 Mid West Science Summit | Inspiring Australia2010 Mid West Science Summit | Inspiring Australia
2010 Mid West Science Summit | Inspiring AustraliaGeoff Crane
 
ESLTP starter workshop - survey response summary
ESLTP starter workshop - survey response summaryESLTP starter workshop - survey response summary
ESLTP starter workshop - survey response summaryTERN Australia
 
TWAS Opportunities and the Importance of Mobilising Young Scientists in sub-S...
TWAS Opportunities and the Importance of Mobilising Young Scientists in sub-S...TWAS Opportunities and the Importance of Mobilising Young Scientists in sub-S...
TWAS Opportunities and the Importance of Mobilising Young Scientists in sub-S...Academy of Science of South Africa (ASSAf)
 
Science Diplomacy 101
Science Diplomacy 101Science Diplomacy 101
Science Diplomacy 101CRDF Global
 
Dr andrew kaniki
Dr andrew kanikiDr andrew kaniki
Dr andrew kanikiSATN
 
Emerging Technologies to Support an Aging Population - BlueStar TeleHealth
Emerging Technologies to Support an Aging Population - BlueStar TeleHealthEmerging Technologies to Support an Aging Population - BlueStar TeleHealth
Emerging Technologies to Support an Aging Population - BlueStar TeleHealthBlueStar TeleHealth
 
{The best technology in number position 2
{The best technology in number position 2{The best technology in number position 2
{The best technology in number position 2sassyswindler8742
 
{The best technology in number position 3
{The best technology in number position 3{The best technology in number position 3
{The best technology in number position 3callousearnings47
 

Ähnlich wie “Does Catalonia need a Chief Scientist?”, MEHRDAD HARIRI (20)

science_of_science_policy_roadmap_2008
science_of_science_policy_roadmap_2008science_of_science_policy_roadmap_2008
science_of_science_policy_roadmap_2008
 
Policy Workshop Introduction by Dr Michael Elves
Policy Workshop Introduction by Dr Michael ElvesPolicy Workshop Introduction by Dr Michael Elves
Policy Workshop Introduction by Dr Michael Elves
 
Science advice to government - Auckland conference
Science advice to government - Auckland conferenceScience advice to government - Auckland conference
Science advice to government - Auckland conference
 
Science & Technology Communication
Science & Technology CommunicationScience & Technology Communication
Science & Technology Communication
 
NZSR_68
NZSR_68NZSR_68
NZSR_68
 
Stevenage Bioscience Catalyst: annual lecture 2014
Stevenage Bioscience Catalyst: annual lecture 2014Stevenage Bioscience Catalyst: annual lecture 2014
Stevenage Bioscience Catalyst: annual lecture 2014
 
Science, Technology & Knowledge Economy
Science, Technology & Knowledge Economy Science, Technology & Knowledge Economy
Science, Technology & Knowledge Economy
 
2010 Mid West Science Summit | Inspiring Australia
2010 Mid West Science Summit | Inspiring Australia2010 Mid West Science Summit | Inspiring Australia
2010 Mid West Science Summit | Inspiring Australia
 
ESLTP starter workshop - survey response summary
ESLTP starter workshop - survey response summaryESLTP starter workshop - survey response summary
ESLTP starter workshop - survey response summary
 
TWAS Opportunities and the Importance of Mobilising Young Scientists in sub-S...
TWAS Opportunities and the Importance of Mobilising Young Scientists in sub-S...TWAS Opportunities and the Importance of Mobilising Young Scientists in sub-S...
TWAS Opportunities and the Importance of Mobilising Young Scientists in sub-S...
 
Science Diplomacy 101
Science Diplomacy 101Science Diplomacy 101
Science Diplomacy 101
 
Communicating Science to Policymakers
Communicating Science to PolicymakersCommunicating Science to Policymakers
Communicating Science to Policymakers
 
Overview of ESRC
Overview of ESRCOverview of ESRC
Overview of ESRC
 
Alpsp Conf 10 Sep 09
Alpsp Conf 10 Sep 09Alpsp Conf 10 Sep 09
Alpsp Conf 10 Sep 09
 
Dr andrew kaniki
Dr andrew kanikiDr andrew kaniki
Dr andrew kaniki
 
Emerging Technologies to Support an Aging Population - BlueStar TeleHealth
Emerging Technologies to Support an Aging Population - BlueStar TeleHealthEmerging Technologies to Support an Aging Population - BlueStar TeleHealth
Emerging Technologies to Support an Aging Population - BlueStar TeleHealth
 
SRUK seminar 8 July 2017
SRUK seminar 8 July 2017SRUK seminar 8 July 2017
SRUK seminar 8 July 2017
 
{The best technology in number position 2
{The best technology in number position 2{The best technology in number position 2
{The best technology in number position 2
 
{The best technology in number position 3
{The best technology in number position 3{The best technology in number position 3
{The best technology in number position 3
 
STS Forum 2016
STS Forum 2016STS Forum 2016
STS Forum 2016
 

Mehr von Biocat, BioRegion of Catalonia

Innovation, Entrepreneurship & Network Thinking: A Growth Model for the Catal...
Innovation, Entrepreneurship & Network Thinking: A Growth Model for the Catal...Innovation, Entrepreneurship & Network Thinking: A Growth Model for the Catal...
Innovation, Entrepreneurship & Network Thinking: A Growth Model for the Catal...Biocat, BioRegion of Catalonia
 
Public session: Lessons learned from successful medtech entrepreneurs - CRAAS...
Public session: Lessons learned from successful medtech entrepreneurs - CRAAS...Public session: Lessons learned from successful medtech entrepreneurs - CRAAS...
Public session: Lessons learned from successful medtech entrepreneurs - CRAAS...Biocat, BioRegion of Catalonia
 
Toby Reid, Managing Director – BioCity Group: “How entrepreneurs can accelera...
Toby Reid, Managing Director – BioCity Group: “How entrepreneurs can accelera...Toby Reid, Managing Director – BioCity Group: “How entrepreneurs can accelera...
Toby Reid, Managing Director – BioCity Group: “How entrepreneurs can accelera...Biocat, BioRegion of Catalonia
 
Presentation Moebio & d·HEALTH Barcelona & CRAASH 2018
Presentation Moebio & d·HEALTH Barcelona & CRAASH 2018Presentation Moebio & d·HEALTH Barcelona & CRAASH 2018
Presentation Moebio & d·HEALTH Barcelona & CRAASH 2018Biocat, BioRegion of Catalonia
 
"Breaking up pharma´s value chain - what can we expect", MICHAEL MÜLLER
"Breaking up pharma´s value chain - what can we expect", MICHAEL MÜLLER"Breaking up pharma´s value chain - what can we expect", MICHAEL MÜLLER
"Breaking up pharma´s value chain - what can we expect", MICHAEL MÜLLERBiocat, BioRegion of Catalonia
 
"Successful model of public and private collaboration: MaRS", ZAYNA KHAYAT
"Successful model of public and private collaboration: MaRS", ZAYNA KHAYAT"Successful model of public and private collaboration: MaRS", ZAYNA KHAYAT
"Successful model of public and private collaboration: MaRS", ZAYNA KHAYATBiocat, BioRegion of Catalonia
 
"A new role for government in accelerating life science innovation: The Massa...
"A new role for government in accelerating life science innovation: The Massa..."A new role for government in accelerating life science innovation: The Massa...
"A new role for government in accelerating life science innovation: The Massa...Biocat, BioRegion of Catalonia
 
Digital Health: “Healthcare Evolution: What is Different This Time”, VISHAL G...
Digital Health: “Healthcare Evolution: What is Different This Time”, VISHAL G...Digital Health: “Healthcare Evolution: What is Different This Time”, VISHAL G...
Digital Health: “Healthcare Evolution: What is Different This Time”, VISHAL G...Biocat, BioRegion of Catalonia
 

Mehr von Biocat, BioRegion of Catalonia (20)

Informe de la BiRegió de Catalunya 2020
Informe de la BiRegió de Catalunya 2020Informe de la BiRegió de Catalunya 2020
Informe de la BiRegió de Catalunya 2020
 
Catalonia BioRegion report 2020
Catalonia BioRegion report 2020Catalonia BioRegion report 2020
Catalonia BioRegion report 2020
 
Biocat presentation
Biocat presentationBiocat presentation
Biocat presentation
 
2019 BioRegion of Catalonia Presentation
2019 BioRegion of Catalonia Presentation2019 BioRegion of Catalonia Presentation
2019 BioRegion of Catalonia Presentation
 
Design Health Barcelona Presentation 2019
Design Health Barcelona Presentation 2019Design Health Barcelona Presentation 2019
Design Health Barcelona Presentation 2019
 
Biocat Report 2017 Presentation
Biocat Report 2017 PresentationBiocat Report 2017 Presentation
Biocat Report 2017 Presentation
 
Innovation, Entrepreneurship & Network Thinking: A Growth Model for the Catal...
Innovation, Entrepreneurship & Network Thinking: A Growth Model for the Catal...Innovation, Entrepreneurship & Network Thinking: A Growth Model for the Catal...
Innovation, Entrepreneurship & Network Thinking: A Growth Model for the Catal...
 
Public session: Lessons learned from successful medtech entrepreneurs - CRAAS...
Public session: Lessons learned from successful medtech entrepreneurs - CRAAS...Public session: Lessons learned from successful medtech entrepreneurs - CRAAS...
Public session: Lessons learned from successful medtech entrepreneurs - CRAAS...
 
EIT Health Presentation | CRAASH Barcelona
EIT Health Presentation | CRAASH BarcelonaEIT Health Presentation | CRAASH Barcelona
EIT Health Presentation | CRAASH Barcelona
 
CIMIT (Boston) Presentation | CRAASH Barcelona
CIMIT (Boston) Presentation | CRAASH BarcelonaCIMIT (Boston) Presentation | CRAASH Barcelona
CIMIT (Boston) Presentation | CRAASH Barcelona
 
CRAASH Barcelona Presentation
CRAASH Barcelona PresentationCRAASH Barcelona Presentation
CRAASH Barcelona Presentation
 
Toby Reid, Managing Director – BioCity Group: “How entrepreneurs can accelera...
Toby Reid, Managing Director – BioCity Group: “How entrepreneurs can accelera...Toby Reid, Managing Director – BioCity Group: “How entrepreneurs can accelera...
Toby Reid, Managing Director – BioCity Group: “How entrepreneurs can accelera...
 
Presentation Moebio & d·HEALTH Barcelona & CRAASH 2018
Presentation Moebio & d·HEALTH Barcelona & CRAASH 2018Presentation Moebio & d·HEALTH Barcelona & CRAASH 2018
Presentation Moebio & d·HEALTH Barcelona & CRAASH 2018
 
Presentation Moebio 2018
Presentation Moebio 2018Presentation Moebio 2018
Presentation Moebio 2018
 
"Breaking up pharma´s value chain - what can we expect", MICHAEL MÜLLER
"Breaking up pharma´s value chain - what can we expect", MICHAEL MÜLLER"Breaking up pharma´s value chain - what can we expect", MICHAEL MÜLLER
"Breaking up pharma´s value chain - what can we expect", MICHAEL MÜLLER
 
"Successful model of public and private collaboration: MaRS", ZAYNA KHAYAT
"Successful model of public and private collaboration: MaRS", ZAYNA KHAYAT"Successful model of public and private collaboration: MaRS", ZAYNA KHAYAT
"Successful model of public and private collaboration: MaRS", ZAYNA KHAYAT
 
"A new role for government in accelerating life science innovation: The Massa...
"A new role for government in accelerating life science innovation: The Massa..."A new role for government in accelerating life science innovation: The Massa...
"A new role for government in accelerating life science innovation: The Massa...
 
Digital Health: “Healthcare Evolution: What is Different This Time”, VISHAL G...
Digital Health: “Healthcare Evolution: What is Different This Time”, VISHAL G...Digital Health: “Healthcare Evolution: What is Different This Time”, VISHAL G...
Digital Health: “Healthcare Evolution: What is Different This Time”, VISHAL G...
 
HEALTH & BIO TEAM DATING
HEALTH & BIO TEAM DATINGHEALTH & BIO TEAM DATING
HEALTH & BIO TEAM DATING
 
The BioRegion of Catalonia at BIO 2015
The BioRegion of Catalonia at BIO 2015The BioRegion of Catalonia at BIO 2015
The BioRegion of Catalonia at BIO 2015
 

Kürzlich hochgeladen

Generative AI in Health Care a scoping review and a persoanl experience.
Generative AI in Health Care a scoping review and a persoanl experience.Generative AI in Health Care a scoping review and a persoanl experience.
Generative AI in Health Care a scoping review and a persoanl experience.Vaikunthan Rajaratnam
 
Pharmacokinetic Models by Dr. Ram D. Bawankar.ppt
Pharmacokinetic Models by Dr. Ram D.  Bawankar.pptPharmacokinetic Models by Dr. Ram D.  Bawankar.ppt
Pharmacokinetic Models by Dr. Ram D. Bawankar.pptRamDBawankar1
 
"Radical excision of DIE in subferile women with deep infiltrating endometrio...
"Radical excision of DIE in subferile women with deep infiltrating endometrio..."Radical excision of DIE in subferile women with deep infiltrating endometrio...
"Radical excision of DIE in subferile women with deep infiltrating endometrio...Sujoy Dasgupta
 
How to cure cirrhosis and chronic hepatitis naturally
How to cure cirrhosis and chronic hepatitis naturallyHow to cure cirrhosis and chronic hepatitis naturally
How to cure cirrhosis and chronic hepatitis naturallyZurück zum Ursprung
 
AORTIC DISSECTION and management of aortic dissection
AORTIC DISSECTION and management of aortic dissectionAORTIC DISSECTION and management of aortic dissection
AORTIC DISSECTION and management of aortic dissectiondrhanifmohdali
 
Different drug regularity bodies in different countries.
Different drug regularity bodies in different countries.Different drug regularity bodies in different countries.
Different drug regularity bodies in different countries.kishan singh tomar
 
pA2 value, Schild plot and pD2 values- applications in pharmacology
pA2 value, Schild plot and pD2 values- applications in pharmacologypA2 value, Schild plot and pD2 values- applications in pharmacology
pA2 value, Schild plot and pD2 values- applications in pharmacologyDeepakDaniel9
 
power point presentation of Clinical evaluation of strabismus
power point presentation of Clinical evaluation  of strabismuspower point presentation of Clinical evaluation  of strabismus
power point presentation of Clinical evaluation of strabismusChandrasekar Reddy
 
CPR.nursingoutlook.pdf , Bsc nursing student
CPR.nursingoutlook.pdf , Bsc nursing studentCPR.nursingoutlook.pdf , Bsc nursing student
CPR.nursingoutlook.pdf , Bsc nursing studentsaileshpanda05
 
Bulimia nervosa ( Eating Disorders) Mental Health Nursing.
Bulimia nervosa ( Eating Disorders) Mental Health Nursing.Bulimia nervosa ( Eating Disorders) Mental Health Nursing.
Bulimia nervosa ( Eating Disorders) Mental Health Nursing.aarjukhadka22
 
Male Infertility, Antioxidants and Beyond
Male Infertility, Antioxidants and BeyondMale Infertility, Antioxidants and Beyond
Male Infertility, Antioxidants and BeyondSujoy Dasgupta
 
historyofpsychiatryinindia. Senthil Thirusangu
historyofpsychiatryinindia. Senthil Thirusanguhistoryofpsychiatryinindia. Senthil Thirusangu
historyofpsychiatryinindia. Senthil Thirusangu Medical University
 
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptxDNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptxMAsifAhmad
 
Male Infertility Panel Discussion by Dr Sujoy Dasgupta
Male Infertility Panel Discussion by Dr Sujoy DasguptaMale Infertility Panel Discussion by Dr Sujoy Dasgupta
Male Infertility Panel Discussion by Dr Sujoy DasguptaSujoy Dasgupta
 
Neurological history taking (2024) .
Neurological  history  taking  (2024)  .Neurological  history  taking  (2024)  .
Neurological history taking (2024) .Mohamed Rizk Khodair
 
SGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdf
SGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdfSGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdf
SGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdfHongBiThi1
 

Kürzlich hochgeladen (20)

Generative AI in Health Care a scoping review and a persoanl experience.
Generative AI in Health Care a scoping review and a persoanl experience.Generative AI in Health Care a scoping review and a persoanl experience.
Generative AI in Health Care a scoping review and a persoanl experience.
 
Biologic therapy ice breaking in rheumatology, Case based approach with appli...
Biologic therapy ice breaking in rheumatology, Case based approach with appli...Biologic therapy ice breaking in rheumatology, Case based approach with appli...
Biologic therapy ice breaking in rheumatology, Case based approach with appli...
 
Pharmacokinetic Models by Dr. Ram D. Bawankar.ppt
Pharmacokinetic Models by Dr. Ram D.  Bawankar.pptPharmacokinetic Models by Dr. Ram D.  Bawankar.ppt
Pharmacokinetic Models by Dr. Ram D. Bawankar.ppt
 
"Radical excision of DIE in subferile women with deep infiltrating endometrio...
"Radical excision of DIE in subferile women with deep infiltrating endometrio..."Radical excision of DIE in subferile women with deep infiltrating endometrio...
"Radical excision of DIE in subferile women with deep infiltrating endometrio...
 
How to cure cirrhosis and chronic hepatitis naturally
How to cure cirrhosis and chronic hepatitis naturallyHow to cure cirrhosis and chronic hepatitis naturally
How to cure cirrhosis and chronic hepatitis naturally
 
AORTIC DISSECTION and management of aortic dissection
AORTIC DISSECTION and management of aortic dissectionAORTIC DISSECTION and management of aortic dissection
AORTIC DISSECTION and management of aortic dissection
 
Different drug regularity bodies in different countries.
Different drug regularity bodies in different countries.Different drug regularity bodies in different countries.
Different drug regularity bodies in different countries.
 
GOUT UPDATE AHMED YEHIA 2024, case based approach with application of the lat...
GOUT UPDATE AHMED YEHIA 2024, case based approach with application of the lat...GOUT UPDATE AHMED YEHIA 2024, case based approach with application of the lat...
GOUT UPDATE AHMED YEHIA 2024, case based approach with application of the lat...
 
pA2 value, Schild plot and pD2 values- applications in pharmacology
pA2 value, Schild plot and pD2 values- applications in pharmacologypA2 value, Schild plot and pD2 values- applications in pharmacology
pA2 value, Schild plot and pD2 values- applications in pharmacology
 
power point presentation of Clinical evaluation of strabismus
power point presentation of Clinical evaluation  of strabismuspower point presentation of Clinical evaluation  of strabismus
power point presentation of Clinical evaluation of strabismus
 
Rheumatoid arthritis Part 1, case based approach with application of the late...
Rheumatoid arthritis Part 1, case based approach with application of the late...Rheumatoid arthritis Part 1, case based approach with application of the late...
Rheumatoid arthritis Part 1, case based approach with application of the late...
 
CPR.nursingoutlook.pdf , Bsc nursing student
CPR.nursingoutlook.pdf , Bsc nursing studentCPR.nursingoutlook.pdf , Bsc nursing student
CPR.nursingoutlook.pdf , Bsc nursing student
 
Bulimia nervosa ( Eating Disorders) Mental Health Nursing.
Bulimia nervosa ( Eating Disorders) Mental Health Nursing.Bulimia nervosa ( Eating Disorders) Mental Health Nursing.
Bulimia nervosa ( Eating Disorders) Mental Health Nursing.
 
Male Infertility, Antioxidants and Beyond
Male Infertility, Antioxidants and BeyondMale Infertility, Antioxidants and Beyond
Male Infertility, Antioxidants and Beyond
 
historyofpsychiatryinindia. Senthil Thirusangu
historyofpsychiatryinindia. Senthil Thirusanguhistoryofpsychiatryinindia. Senthil Thirusangu
historyofpsychiatryinindia. Senthil Thirusangu
 
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptxDNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
 
Male Infertility Panel Discussion by Dr Sujoy Dasgupta
Male Infertility Panel Discussion by Dr Sujoy DasguptaMale Infertility Panel Discussion by Dr Sujoy Dasgupta
Male Infertility Panel Discussion by Dr Sujoy Dasgupta
 
Immune labs basics part 1 acute phase reactants ESR, CRP Ahmed Yehia Ismaeel,...
Immune labs basics part 1 acute phase reactants ESR, CRP Ahmed Yehia Ismaeel,...Immune labs basics part 1 acute phase reactants ESR, CRP Ahmed Yehia Ismaeel,...
Immune labs basics part 1 acute phase reactants ESR, CRP Ahmed Yehia Ismaeel,...
 
Neurological history taking (2024) .
Neurological  history  taking  (2024)  .Neurological  history  taking  (2024)  .
Neurological history taking (2024) .
 
SGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdf
SGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdfSGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdf
SGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdf
 

“Does Catalonia need a Chief Scientist?”, MEHRDAD HARIRI

  • 1. Does Catalonia Need a Chief Science Officer / Advisor ? Mehrdad Hariri CEO & Founder Canadian Science Policy Centre BioCat Forum Nov. 25 2016
  • 11. New institutions of science policy
  • 13. Bosch-Capblanch X, Lavis JN, Lewin S, Atun R, Røttingen J-A, Dröschel D, et al. (2012) Guidance for Evidence-Informed Policies about Health Systems: Rationale for and Challenges of Guidance Development. PLoS Med 9(3): e1001185. doi:10.1371/journal.pmed.1001185
  • 14. Cycle of Interaction: Science Society Policy Maker Adopted from: http://weadapt.org/
  • 17. • the complexity, multidisciplinary, and ever-changing nature of science and technology of the 21st century requires efficient, energetic and agile institutions to ensure the interconnection among various elements of innovation system, including the society at large.
  • 23. Why science adviser / officer
  • 24. Officer vs Advisor Chief Science Officer (CSO) Chief Science Advisor (CSA) Responsible for capacity development of the overall science enterprise or government funded science Responsible for providing independent scientific advice to the Prime Minister and the cabinet
  • 25. Officer vs Advisor Chief Science Officer (CSO) Chief Science Advisor (CSA) Responsible for capacity development of the overall science enterprise or government funded science Responsible for providing independent scientific advice to the Prime Minister and the cabinet Jurisdiction: Policy for Science Jurisdiction: Science for Policy
  • 26. Officer vs Advisor Chief Science Officer (CSO) Chief Science Advisor (CSA) Responsible for capacity development of the overall science enterprise or government funded science Responsible for providing independent scientific advice to the Prime Minister and the cabinet Jurisdiction: Policy for Science Jurisdiction: Science for Policy Ensures the well-being of the science enterprise, its management, coordination, and collaboration, domestically and internationally Provides the best scientific advice on emerging matters for high-level decision- making.
  • 27. Officer vs Advisor Chief Science Officer (CSO) Chief Science Advisor (CSA) Responsible for capacity development of the overall science enterprise or government funded science Responsible for providing independent scientific advice to the Prime Minister and the cabinet Jurisdiction: Policy for Science Jurisdiction: Science for Policy CEO of Science Enterprise/ or Government Science (depending on the extension of mandate) No Formal Executive Responsibility Ensures the well-being of the science enterprise, its management, coordination, and collaboration, domestically and internationally Provides the best scientific advice on emerging matters for high-level decision- making.
  • 28. Officer vs Advisor Chief Science Officer (CSO) Chief Science Advisor (CSA) Responsible for capacity development of the overall science enterprise or government funded science Responsible for providing independent scientific advice to the Prime Minister and the cabinet Jurisdiction: Policy for Science Jurisdiction: Science for Policy CEO of Science Enterprise/ or Government Science (depending on the extension of mandate) No Formal Executive Responsibility Functions as part of the Ministry of Science and or Innovation Independent, Arm’s Length office, functioning under the PMO Ensures the well-being of the science enterprise, its management, coordination, and collaboration, domestically and internationally Provides the best scientific advice on emerging matters for high-level decision- making.
  • 29. Science Advisory: USA The Office of Science and Technology Policy (OSTP) is a department of the United States government, part of the Executive Office of the President (EOP), established by the United States Congress in 1976, broad mandate to advise the President on the effects of science and technology on domestic and international affairs.
  • 30. Science Advisory: USA Mission: 1.To provide the President and his senior staff with accurate, relevant, and timely scientific and technical advice on all matters of consequence; 2.To ensure that the policies of the Executive Branch are informed by sound science 3.Too ensure that the scientific and technical work of the Executive Branch is properly coordinated so as to provide the greatest benefit to society.
  • 32. Science Advisory: UK Every government department has a chief scientific Advisor (CSA). Departmental CSAs work together under the leadership of the Government’s Chief Scientific Advisor to support each other and to address and advise on cross-cutting issues. They do this primarily through the Chief Scientific Advisors network. The network advises the Government Chief Scientific Advisor on all aspects of policy on science and technology.
  • 33. Science Advisory: UK In particular, they: 1. Provide advice to ministers, through the Cabinet committee system 2. Discuss and facilitate implementation of policy on science, technology, engineering and mathematics (STEM) 3. Identify and share good practices in STEM-related areas, including the use of scientific advice in policy-making 4. Facilitate communication on particular high profile STEM-related issues and those posing new challenges for government
  • 35. Science Advisory: New Zealand The primary task of the Chief Scientific Advisor is to provide the Prime Minister strategic and operational advice on science and science policy issues. Other tasks include: 1.Advise on matters of science policy in areas where the Prime Minister specifically requests.  2.Advise Prime Minister on specific matters related to science 3.Promote the public understanding of, and engagement with, science, particularly with young people. 4.Build international relationships. Science can be an important diplomatic tool, generating trust and confidence between nations and opening strategic opportunities for cooperation. 5.Serve as a conduit of alerts that might arise where scientific progress shows either opportunity or threat for New Zealand. 
  • 37. Science Advisory: Australia The world, and Australia with it, is faced with increasingly complex challenges and opportunities, most of which require significant input from science in order to address them fully and appropriately. It is essential then, that the Australian available, to be used to help inform the best course of action for Australian Government has access to the highest calibre independent, and authoritative scientific advice. The Chief Scientist has the opportunity to help bring together extensive national and international scientific networks to assist in providing the most up to date and scientifically robust advice. Through international networks the Chief Scientist is also able to help discuss and affect this at a global level. This is a key and unique aspect of the role.
  • 38. Science and Technology and innovation Council (STIC)
  • 40. Scotland Provides expert scientific advice to the Scottish Government about science-related issues, evidence and new developments that may have an impact on the Scottish Government's work Champions the use of science to inform policy development across the Scottish Government Supports Scotland's world-leading science base and its potential to benefit Scotland's economy, people and environment
  • 41. Quebec •To advise the Minister of Economy, Science and Innovation on matters pertaining to the development of research and science; •To chair the Boards of Directors of each of the three research funds; •To coordinate issues of common concern to the three funds and cross-sectoral research activities; •To ensure the consolidation and integration of the three research funds’ administrative activities; •To promote careers in research and scientific culture.
  • 42. Does Catalonia Need a Chief Science Officer / Advisor ?
  • 43. Determinant of such office • Objectives • Stakeholders consultation
  • 44. Innovation Systems Adopted from: Review of federal support for R&D